Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Methotrexate in atherogenesis and cholesterol metabolism.

Coomes E, Chan ES, Reiss AB.

Cholesterol. 2011;2011:503028. doi: 10.1155/2011/503028. Epub 2011 Feb 22.

2.
3.

Blood lipid profiles and peripheral blood mononuclear cell cholesterol metabolism gene expression in patients with and without methotrexate treatment.

Chen DY, Chih HM, Lan JL, Chang HY, Chen WW, Chiang EP.

BMC Med. 2011 Jan 13;9:4. doi: 10.1186/1741-7015-9-4.

4.

Pitavastatin effect on ATP binding cassette A1-mediated lipid efflux from macrophages: evidence for liver X receptor (LXR)-dependent and LXR-independent mechanisms of activation by cAMP.

Zanotti I, Potì F, Favari E, Steffensen KR, Gustafsson JA, Bernini F.

J Pharmacol Exp Ther. 2006 Apr;317(1):395-401. Epub 2006 Jan 13.

5.
7.

Regulation and mechanisms of ATP-binding cassette transporter A1-mediated cellular cholesterol efflux.

Wang N, Tall AR.

Arterioscler Thromb Vasc Biol. 2003 Jul 1;23(7):1178-84. Epub 2003 May 8.

8.

Scavenger receptor BI and ATP-binding cassette transporter A1 in reverse cholesterol transport and atherosclerosis.

Van Eck M, Pennings M, Hoekstra M, Out R, Van Berkel TJ.

Curr Opin Lipidol. 2005 Jun;16(3):307-15. Review.

PMID:
15891392
9.

Contribution of D4-F to ABCA1 expression and cholesterol efflux in THP-1 macrophage-derived foam cells.

Liu XH, Xiao J, Mo ZC, Yin K, Jiang J, Cui LB, Tan CZ, Tang YL, Liao DF, Tang CK.

J Cardiovasc Pharmacol. 2010 Sep;56(3):309-19. doi: 10.1097/FJC.0b013e3181edaf69.

PMID:
20625316
10.

Reverse cholesterol transport and cholesterol efflux in atherosclerosis.

Ohashi R, Mu H, Wang X, Yao Q, Chen C.

QJM. 2005 Dec;98(12):845-56. Epub 2005 Oct 28. Review.

11.

Inhibition of ERK1/2 and activation of liver X receptor synergistically induce macrophage ABCA1 expression and cholesterol efflux.

Zhou X, Yin Z, Guo X, Hajjar DP, Han J.

J Biol Chem. 2010 Feb 26;285(9):6316-26. doi: 10.1074/jbc.M109.073601. Epub 2009 Dec 25.

12.

PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway.

Ruan XZ, Moorhead JF, Fernando R, Wheeler DC, Powis SH, Varghese Z.

J Am Soc Nephrol. 2003 Mar;14(3):593-600.

13.

CD36-mediated cholesterol efflux is associated with PPARgamma activation via a MAPK-dependent COX-2 pathway in macrophages.

Bujold K, Rhainds D, Jossart C, Febbraio M, Marleau S, Ong H.

Cardiovasc Res. 2009 Aug 1;83(3):457-64. doi: 10.1093/cvr/cvp118. Epub 2009 Apr 17.

14.

Cholesterol efflux via ATP-binding cassette transporter A1 (ABCA1) and cholesterol uptake via the LDL receptor influences cholesterol-induced impairment of beta cell function in mice.

Kruit JK, Kremer PH, Dai L, Tang R, Ruddle P, de Haan W, Brunham LR, Verchere CB, Hayden MR.

Diabetologia. 2010 Jun;53(6):1110-9. doi: 10.1007/s00125-010-1691-2. Epub 2010 Mar 13.

PMID:
20229095
15.

Purification of ATP-binding cassette transporter A1 and associated binding proteins reveals the importance of beta1-syntrophin in cholesterol efflux.

Okuhira K, Fitzgerald ML, Sarracino DA, Manning JJ, Bell SA, Goss JL, Freeman MW.

J Biol Chem. 2005 Nov 25;280(47):39653-64. Epub 2005 Sep 28.

16.

ATP-binding cassette transporter A1: regulation of cholesterol efflux.

Knight BL.

Biochem Soc Trans. 2004 Feb;32(Pt 1):124-7. Review.

PMID:
14748729
17.

ATP-Binding cassette cholesterol transporters and cardiovascular disease.

Oram JF, Vaughan AM.

Circ Res. 2006 Nov 10;99(10):1031-43. Review.

18.
19.

cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts.

Haidar B, Denis M, Krimbou L, Marcil M, Genest J Jr.

J Lipid Res. 2002 Dec;43(12):2087-94.

20.
Items per page

Supplemental Content

Write to the Help Desk